Pure Health Products Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 4.55 M
as on 18-07-2024
- Company Age 36 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 179.47 Cr
as on 18-07-2024
- Satisfied Charges ₹ 1.78 Cr
as on 18-07-2024
- Revenue %
(FY 2022)
- Profit -70.34%
(FY 2022)
- Ebitda -70.34%
(FY 2022)
- Net Worth -1.91%
(FY 2022)
- Total Assets -0.12%
(FY 2022)
About Pure Health Products
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.55 M.
The company currently has active open charges totaling ₹179.47 Cr. The company has closed loans amounting to ₹1.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
Maneesh Sapte and Vinay Sapte serve as directors at the Company.
- CIN/LLPIN
U85199PN1988PTC047757
- Company No.
047757
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jun 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pure Health Products?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maneesh Sapte  | Director | 14-Jan-2012 | Current |
| Vinay Sapte | Director | 03-Aug-2005 | Current |
Financial Performance and Corporate Structure Insights of Pure Health Products.
Pure Health Products Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 70.34% decrease in profit. The company's net worth dipped by a decrease of 1.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pure Health Products?
In 2022, Pure Health Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Maneesh Pharmaceuticals LimitedActive 39 years 4 monthsManeesh Sapte and Vinay Sapte are mutual person
- Pharmanova Specialties Private LimitedActive 10 years 10 months
Maneesh Sapte and Vinay Sapte are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Il & Fs Trust Company Limited Creation Date: 03 Jun 2008 | ₹178.83 Cr | Open |
Union Bank Of India Creation Date: 30 Oct 1999 | ₹4.00 M | Open |
The Union Bank Of India Creation Date: 01 Aug 1995 | ₹2.40 M | Open |
How Many Employees Work at Pure Health Products?
Unlock and access historical data on people associated with Pure Health Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pure Health Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pure Health Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
